MoonLake Immunotherapeutics Quarterly Return On Assets in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
MoonLake Immunotherapeutics quarterly/annual Return On Assets history and growth rate from Q4 2021 to Q3 2024.
  • MoonLake Immunotherapeutics Return On Assets for the quarter ending September 30, 2024 was -15 %, a 6.69% decline year-over-year.
  • MoonLake Immunotherapeutics annual Return On Assets for 2023 was -9 %, a 77.7% increase from 2022.
  • MoonLake Immunotherapeutics annual Return On Assets for 2022 was -40.4 %, a 697% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -15 -0.94 -6.69% Jul 1, 2024 Sep 30, 2024
Q2 2024 -10.3 +12 +53.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -7.76 +44.4 +85.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -9 +31.4 +77.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -14.1 -10.7 -317% Jul 1, 2023 Sep 30, 2023
Q2 2023 -22.3 -22.5 -11699% Apr 1, 2023 Jun 30, 2023
Q1 2023 -52.1 -35 -203% Jan 1, 2023 Mar 31, 2023
Q4 2022 -40.4 -35.3 -697% Oct 1, 2022 Dec 31, 2022
Q3 2022 -3.37 Jul 1, 2022 Sep 30, 2022
Q2 2022 0.19 Apr 1, 2022 Jun 30, 2022
Q1 2022 -17.2 Jan 1, 2022 Mar 31, 2022
Q4 2021 -5.06 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.